HK1065708A1 - Pharmaceutical composition based on macrolides for topical application in ophthalmology - Google Patents

Pharmaceutical composition based on macrolides for topical application in ophthalmology

Info

Publication number
HK1065708A1
HK1065708A1 HK04108553.8A HK04108553A HK1065708A1 HK 1065708 A1 HK1065708 A1 HK 1065708A1 HK 04108553 A HK04108553 A HK 04108553A HK 1065708 A1 HK1065708 A1 HK 1065708A1
Authority
HK
Hong Kong
Prior art keywords
macrolides
ophthalmology
pharmaceutical composition
topical application
composition based
Prior art date
Application number
HK04108553.8A
Other languages
English (en)
Inventor
Jacques Luyckx
Frederic Pilotaz
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Publication of HK1065708A1 publication Critical patent/HK1065708A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK04108553.8A 2001-04-12 2004-11-01 Pharmaceutical composition based on macrolides for topical application in ophthalmology HK1065708A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
PCT/FR2002/001263 WO2002083178A1 (fr) 2001-04-12 2002-04-11 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (1)

Publication Number Publication Date
HK1065708A1 true HK1065708A1 (en) 2005-03-04

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108553.8A HK1065708A1 (en) 2001-04-12 2004-11-01 Pharmaceutical composition based on macrolides for topical application in ophthalmology

Country Status (31)

Country Link
US (1) US7064109B2 (ko)
EP (1) EP1377316B1 (ko)
JP (2) JP4558275B2 (ko)
KR (1) KR100835002B1 (ko)
CN (1) CN1496270B (ko)
AR (1) AR034033A1 (ko)
AT (1) ATE397460T1 (ko)
BR (1) BRPI0208367B8 (ko)
CA (1) CA2443728C (ko)
CY (1) CY1108302T1 (ko)
CZ (1) CZ300213B6 (ko)
DE (1) DE60226962D1 (ko)
DK (1) DK1377316T3 (ko)
EA (1) EA008088B1 (ko)
EG (1) EG23169A (ko)
ES (1) ES2307754T3 (ko)
FR (1) FR2823441B1 (ko)
HK (1) HK1065708A1 (ko)
HR (1) HRP20030907B1 (ko)
HU (1) HU230459B1 (ko)
MA (1) MA27005A1 (ko)
MX (1) MXPA03009349A (ko)
OA (1) OA12462A (ko)
PA (1) PA8543401A1 (ko)
PE (1) PE20021082A1 (ko)
PL (1) PL204403B1 (ko)
PT (1) PT1377316E (ko)
SI (1) SI1377316T1 (ko)
TN (1) TNSN03091A1 (ko)
WO (1) WO2002083178A1 (ko)
ZA (1) ZA200307718B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
CA2679448A1 (en) * 2007-02-28 2008-09-04 Aciex, Inc. Methods and compositions for normalizing meibomian gland secretions
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
EP3478269A4 (en) * 2016-06-29 2020-04-08 Otonomy, Inc. OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
DK3266446T3 (en) * 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
ATE271390T1 (de) * 1997-12-02 2004-08-15 Pfizer Prod Inc Verwendung von azithromycin zur topischen behandlung von augeninfektionen
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
CA2443728C (fr) 2011-01-04
EG23169A (en) 2004-06-30
EP1377316B1 (fr) 2008-06-04
BR0208367B1 (pt) 2013-11-12
US7064109B2 (en) 2006-06-20
BR0208367A (pt) 2004-03-09
HRP20030907B1 (en) 2010-04-30
TNSN03091A1 (fr) 2005-12-23
EP1377316A1 (fr) 2004-01-07
ES2307754T3 (es) 2008-12-01
PA8543401A1 (es) 2003-01-24
ZA200307718B (en) 2004-09-02
HUP0303864A2 (hu) 2004-03-01
PE20021082A1 (es) 2002-12-18
KR100835002B1 (ko) 2008-06-09
JP2010043109A (ja) 2010-02-25
PL204403B1 (pl) 2010-01-29
WO2002083178A1 (fr) 2002-10-24
JP2004526763A (ja) 2004-09-02
JP4558275B2 (ja) 2010-10-06
CZ300213B6 (cs) 2009-03-18
CN1496270A (zh) 2004-05-12
HU230459B1 (hu) 2016-07-28
AR034033A1 (es) 2004-01-21
OA12462A (fr) 2006-06-24
ATE397460T1 (de) 2008-06-15
DE60226962D1 (de) 2008-07-17
CN1496270B (zh) 2010-05-26
SI1377316T1 (sl) 2008-10-31
EA008088B1 (ru) 2007-02-27
FR2823441A1 (fr) 2002-10-18
HRP20030907A2 (en) 2004-02-29
MXPA03009349A (es) 2004-11-12
PT1377316E (pt) 2008-09-15
PL363538A1 (en) 2004-11-29
CA2443728A1 (fr) 2002-10-24
BRPI0208367B8 (pt) 2021-05-25
EA200301108A1 (ru) 2004-04-29
FR2823441B1 (fr) 2004-09-10
KR20030088466A (ko) 2003-11-19
CZ20032771A3 (cs) 2004-01-14
JP5170780B2 (ja) 2013-03-27
HUP0303864A3 (en) 2012-07-30
CY1108302T1 (el) 2014-02-12
MA27005A1 (fr) 2004-12-20
US20040197340A1 (en) 2004-10-07
DK1377316T3 (da) 2008-09-22

Similar Documents

Publication Publication Date Title
AU2001271055A1 (en) Pharmaceutical composition improved in peroral absorbability
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
HUP0204555A3 (en) Pharmaceutical composition
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
AU2002257582A1 (en) Pharmaceutical formulation
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
HK1065708A1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
AU2001290239A1 (en) Medicinal composition
IL154238A0 (en) Pharmaceutical composition
AU4085201A (en) Pharmaceutical composition
GB9902227D0 (en) Pharmaceutical composition for topical administration
AU2002354460A1 (en) Medicinal composition
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2002304524A1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AUPR529701A0 (en) Pharmaceutical composition
AU2001230490A1 (en) Pharmaceutical formulation
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
AU2002100921A4 (en) Pharmaceutical composition
AUPQ678400A0 (en) Pharmaceutical composition
AU2002339723A1 (en) Pharmaceutical composition comprising chito-oligomers

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220410